Author:
Horigome Toshiro,Hino Kimihiro,Toyoshiba Hiroyoshi,Shindo Norihisa,Funaki Kei,Eguchi Yoko,Kitazawa Momoko,Fujita Takanori,Mimura Masaru,Kishimoto Taishiro
Abstract
AbstractIn recent years, studies on the use of natural language processing (NLP) approaches to identify dementia have been reported. Most of these studies used picture description tasks or other similar tasks to encourage spontaneous speech, but the use of free conversation without requiring a task might be easier to perform in a clinical setting. Moreover, free conversation is unlikely to induce a learning effect. Therefore, the purpose of this study was to develop a machine learning model to discriminate subjects with and without dementia by extracting features from unstructured free conversation data using NLP. We recruited patients who visited a specialized outpatient clinic for dementia and healthy volunteers. Participants’ conversation was transcribed and the text data was decomposed from natural sentences into morphemes by performing a morphological analysis using NLP, and then converted into real-valued vectors that were used as features for machine learning. A total of 432 datasets were used, and the resulting machine learning model classified the data for dementia and non-dementia subjects with an accuracy of 0.900, sensitivity of 0.881, and a specificity of 0.916. Using sentence vector information, it was possible to develop a machine-learning algorithm capable of discriminating dementia from non-dementia subjects with a high accuracy based on free conversation.
Funder
Japan Agency for Medical Research and Development
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Prince, M. et al. World Alzheimer Report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends. in Alzheimer’s Disease International, London, UK 1–82 (2015).
2. Seltzer, B. et al. Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial. Arch. Neurol. 61, 1852–1856 (2004).
3. Rountree, S. D. et al. Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease. Alzheimers Res. Ther. 1, 1–7 (2009).
4. Ngandu, T. et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385, 2255–2263 (2015).
5. Logsdon, R. G. et al. Early-stage memory loss support groups: outcomes from a randomized controlled clinical trial. J. Gerontol. B Psychol. Sci. Soc. Sci. 65, 691–697 (2010).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献